ReferIndia News Evergreening in Patents-Why the Delhi HC’s semaglutide ruling matters for UPSC

ReferIndia News

Sponsored

Easy Steps, Real Earnings

Start Earning
News Image

Evergreening in Patents-Why the Delhi HC’s semaglutide ruling matters for UPSC

Published on: Dec. 9, 2025, 3:29 p.m. | Source: The Indian Express

Explore the critical issue of evergreening in patents, its impact on affordable medicines, and recent legal developments involving semaglutide and pharma giants in India. Understand the implications for health and innovation.

Checkout more news
Ad Banner

One Partner for All Your Financial Goals

From financial planning and insurance to portfolio management and retirement solutions—get everything under one trusted roof.

Book Consultation
ReferIndia News contact